A detailed history of Strategic Financial Concepts, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Financial Concepts, LLC holds 415,147 shares of LLY stock, worth $331 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
415,147
Previous 608 68180.76%
Holding current value
$331 Million
Previous $473 Million 94.31%
% of portfolio
0.02%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $300 Million - $377 Million
414,539 Added 68180.76%
415,147 $26.9 Million
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $360,057 - $481,706
608 New
608 $473 Million
Q3 2023

Nov 07, 2023

SELL
$434.7 - $599.3 $72,594 - $100,083
-167 Reduced 27.02%
451 $242 Million
Q2 2023

Sep 06, 2023

BUY
$350.74 - $468.98 $8,768 - $11,724
25 Added 4.22%
618 $290 Million
Q1 2023

Sep 06, 2023

BUY
$310.63 - $364.82 $184,203 - $216,338
593 New
593 $204 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strategic Financial Concepts, LLC Portfolio

Follow Strategic Financial Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Concepts, LLC with notifications on news.